Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

149.02
-1.4150-0.94%
Volume:185.36K
Turnover:27.88M
Market Cap:184.88B
PE:-56.98
High:151.16
Open:151.16
Low:148.91
Close:150.43
52wk High:157.29
52wk Low:114.02
Shares:1.24B
Float Shares:1.24B
Volume Ratio:0.91
T/O Rate:0.01%
Dividend:3.22
Dividend Rate:2.16%
EPS(TTM):-2.6150
EPS(LYR):6.78
ROE:-20.68%
ROA:14.09%
PB:15.63
PE(LYR):21.98

Loading ...

Sat Out Gilead Sciences' Rally? Here Is What Holders Saw

Simply Wall St.
·
11 hours ago

Moderna Inc. Stock Slides 5.0%, Underperforms Peers

Dow Jones
·
17 hours ago

Gilead Sciences' Yeztugo Survey Supports Long-Term Growth Outlook, BofA Says

MT Newswires Live
·
Yesterday

BofA Securities Adjusts Gilead Sciences Price Target to $168 From $162, Maintains Buy Rating

MT Newswires Live
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), Merit Medical Systems (MMSI) and Gilead Sciences (GILD)

TIPRANKS
·
Yesterday

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 10

Moderna Inc. Stock Advances 14.2%, Outperforms Peers

Dow Jones
·
Oct 10

Pharma Stocks Jump With Novavax up 12%, Moderna up 6%

Tiger Newspress
·
Oct 09

UBS Sticks to Their Buy Rating for Gilead Sciences (GILD)

TIPRANKS
·
Oct 09

How Earnings Beat At Gilead Sciences Stock Has Changed Its Investment Story

Simply Wall St.
·
Oct 09

Analysts’ Top Healthcare Picks: Gilead Sciences (GILD), Rhythm Pharmaceuticals (RYTM)

TIPRANKS
·
Oct 08

Moderna Inc. Stock Rises 4.8%, Outperforms Peers

Dow Jones
·
Oct 08

Gilead Sciences is Maintained at Overweight by JP Morgan

Dow Jones
·
Oct 08

Pharma Stocks Rally With Amgen, Gilead Sciences up 3%

Tiger Newspress
·
Oct 07

Early notable gainers among liquid option names on October 7th

TIPRANKS
·
Oct 07

JPMorgan Adjusts Price Target on Gilead Sciences to $170 From $160

MT Newswires Live
·
Oct 07

J.P. Morgan Remains a Buy on Gilead Sciences (GILD)

TIPRANKS
·
Oct 07

US Research Roundup-Allstate, Caribou Biosciences, Zscaler

Reuters
·
Oct 07

Why Vaxcyte Chose A 1.5% Convertible

Macro World​
·
Oct 07

Gilead : JP Morgan Raises Target Price to $170 from $160

THOMSON REUTERS
·
Oct 07